vs
NovoCure Ltd（NVCR）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
NovoCure Ltd的季度营收约是REPUBLIC BANCORP INC的1.8倍（$174.1M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs -40.9%，领先65.1%），NovoCure Ltd同比增速更快（12.3% vs 5.3%），过去两年NovoCure Ltd的营收复合增速更高（7.6% vs -11.5%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
NVCR vs RBCAA — 直观对比
营收规模更大
NVCR
是对方的1.8倍
$94.3M
营收增速更快
NVCR
高出7.0%
5.3%
净利率更高
RBCAA
高出65.1%
-40.9%
两年增速更快
NVCR
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $94.3M |
| 净利润 | $-71.1M | $22.8M |
| 毛利率 | 77.6% | — |
| 营业利润率 | — | 29.3% |
| 净利率 | -40.9% | 24.2% |
| 营收同比 | 12.3% | 5.3% |
| 净利润同比 | -107.3% | 20.0% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRBCAA
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $94.3M | ||
| Q3 25 | $167.2M | $93.5M | ||
| Q2 25 | $158.8M | $93.8M | ||
| Q1 25 | $155.0M | $135.8M | ||
| Q4 24 | $161.3M | $89.5M | ||
| Q3 24 | $155.1M | $88.1M | ||
| Q2 24 | $150.4M | $86.9M |
净利润NVCRRBCAA
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $22.8M | ||
| Q3 25 | $-37.3M | $29.7M | ||
| Q2 25 | $-40.1M | $31.5M | ||
| Q1 25 | $-34.3M | $47.3M | ||
| Q4 24 | $-65.9M | $19.0M | ||
| Q3 24 | $-30.6M | $26.5M | ||
| Q2 24 | $-33.4M | $25.2M |
毛利率NVCRRBCAA
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | — | ||
| Q3 25 | 73.2% | — | ||
| Q2 25 | 73.9% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 79.2% | — | ||
| Q3 24 | 77.2% | — | ||
| Q2 24 | 77.0% | — |
营业利润率NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 29.3% | ||
| Q3 25 | -21.5% | 40.4% | ||
| Q2 25 | -24.9% | 43.0% | ||
| Q1 25 | -24.4% | 44.1% | ||
| Q4 24 | -39.3% | 25.8% | ||
| Q3 24 | -20.7% | 38.4% | ||
| Q2 24 | -22.3% | 37.0% |
净利率NVCRRBCAA
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | 24.2% | ||
| Q3 25 | -22.3% | 31.8% | ||
| Q2 25 | -25.3% | 33.5% | ||
| Q1 25 | -22.1% | 34.8% | ||
| Q4 24 | -40.9% | 21.2% | ||
| Q3 24 | -19.7% | 30.1% | ||
| Q2 24 | -22.2% | 29.0% |
每股收益（稀释后）NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | — | ||
| Q3 25 | $-0.33 | — | ||
| Q2 25 | $-0.36 | — | ||
| Q1 25 | $-0.31 | — | ||
| Q4 24 | $-0.61 | — | ||
| Q3 24 | $-0.28 | — | ||
| Q2 24 | $-0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $330.7M | $1.1B |
| 总资产 | $787.9M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVCRRBCAA
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $220.0M | ||
| Q3 25 | $342.1M | $484.2M | ||
| Q2 25 | $149.6M | $484.8M | ||
| Q1 25 | $127.3M | $793.0M | ||
| Q4 24 | $163.8M | $432.2M | ||
| Q3 24 | $185.4M | $530.9M | ||
| Q2 24 | $164.8M | $400.1M |
股东权益NVCRRBCAA
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $1.1B | ||
| Q3 25 | $341.3M | $1.1B | ||
| Q2 25 | $349.4M | $1.1B | ||
| Q1 25 | $362.0M | $1.0B | ||
| Q4 24 | $360.2M | $992.0M | ||
| Q3 24 | $360.8M | $979.7M | ||
| Q2 24 | $361.8M | $955.4M |
总资产NVCRRBCAA
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $7.0B | ||
| Q3 25 | $1.4B | $7.0B | ||
| Q2 25 | $1.2B | $7.0B | ||
| Q1 25 | $1.2B | $7.1B | ||
| Q4 24 | $1.2B | $6.8B | ||
| Q3 24 | $1.2B | $6.7B | ||
| Q2 24 | $1.2B | $6.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | $-18.0M | $168.2M | ||
| Q3 25 | $20.6M | $33.3M | ||
| Q2 25 | $-15.9M | $8.4M | ||
| Q1 25 | $-35.7M | $93.2M | ||
| Q4 24 | $-3.5M | $149.0M | ||
| Q3 24 | $10.4M | $51.3M | ||
| Q2 24 | $-1.7M | $4.0M |
自由现金流NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | $-22.9M | $161.1M | ||
| Q3 25 | $14.9M | $30.8M | ||
| Q2 25 | $-21.4M | $5.2M | ||
| Q1 25 | $-46.3M | $91.6M | ||
| Q4 24 | $-12.4M | $143.2M | ||
| Q3 24 | $-307.0K | $49.8M | ||
| Q2 24 | $-13.2M | $2.7M |
自由现金流率NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | -13.1% | 170.9% | ||
| Q3 25 | 8.9% | 32.9% | ||
| Q2 25 | -13.5% | 5.5% | ||
| Q1 25 | -29.9% | 67.4% | ||
| Q4 24 | -7.7% | 160.0% | ||
| Q3 24 | -0.2% | 56.5% | ||
| Q2 24 | -8.8% | 3.1% |
资本支出强度NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 7.5% | ||
| Q3 25 | 3.4% | 2.6% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 6.8% | 1.2% | ||
| Q4 24 | 5.5% | 6.5% | ||
| Q3 24 | 6.9% | 1.7% | ||
| Q2 24 | 7.6% | 1.5% |
现金转化率NVCRRBCAA
| Q1 26 | — | — | ||
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
